TRITON-X is most effective among three decellularization agents for ACL tissue engineering

Journal of Orthopaedic Research

Volumn 27, Issue 12, 2009, Pages 1612-1618

  Vavken, Patrick ^a   Joshi, Shilpa ^a   Murray, Martha M ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

ACL repair; Decellularization; Tissue engineering

Indexed keywords

COLLAGEN; DODECYL SULFATE SODIUM; GLYCOSAMINOGLYCAN; OCTOXINOL; TRYPSIN;

ANIMAL EXPERIMENT; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; CONTROLLED STUDY; DECELLULARIZATION; DNA CONTENT; FEMALE; FIBROBLAST; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; TISSUE ENGINEERING;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; BONE TRANSPLANTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN; DNA; FEMALE; FIBROBLASTS; MALE; POLYETHYLENE GLYCOLS; SODIUM DODECYL SULFATE; SURFACE-ACTIVE AGENTS; SWINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTATION, HOMOLOGOUS;

EID: 72049124062     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20932     Document Type: Article

References (46)

1. Liden M, Sernert N, Rostgard-Christensen L, et al. 2008. Osteoarthritic changes after anterior cruciate ligament reconstruction using bone-patellar tendon-bone or hamstring tendon autografts: a retrospective, 7-year radiographic and clinical follow-up study. Arthroscopy 24:899-908.
2. Neuman P, Englund M, Kostogiannis I, et al. 2008. Prevalence of tibiofemoral osteoarthritis 15 years after nonoperative treatment of anterior cruciate ligament injury: a prospective cohort study. Am J Sports Med 36:1717-1725.
3. Jones AP, Sidhom S, Sefton G. 2007. Long-term clinical review (10-20 years) after reconstruction of the anterior cruciate ligament using the Leeds-Keio synthetic ligament. J Long-Term Eff Med Implants 17:59-69. (Pubitemid 351260581)
4. Kessler MA, Behrend H, Henz S, et al. 2008. Function, osteoarthritis and activity after ACL-rupture: 11 years follow-up results of conservative versus reconstructive treatment. Knee Surg Sports Traumatol Arthrosc 16:442-448.
5. Murray MM, Spindler KP, Abreu E, et al. 2007. Collagen-platelet rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament. J Orthop Res 25:81-91. (Pubitemid 46070734)
6. Murray MM, Spindler KP, Ballard P, et al. 2007. Enhanced histologic repair in a central wound in the anterior cruciate ligament with a collagen-platelet-rich plasma scaffold. J Orthop Res 25:1007-1017. (Pubitemid 47233077)
7. Murray MM, Spindler KP, Devin C, et al. 2006. Use of a collagen-platelet rich plasma scaffold to stimulate healing of a central defect in the canine ACL. J Orthop Res 24:820-830. (Pubitemid 43804978)
8. Spindler KP, Murray MM, Carey JL, et al. 2009. The use of platelets to affect functional healing of an anterior cruciate ligament (ACL) autograft in a caprine ACL reconstruction model. J Orthop Res 27:631-638.
9. Fufa D, Shealy B, Jacobson M, et al. 2008. Activation of platelet-rich plasma using soluble type I collagen. J Oral Maxillofac Surg 66:684-690.
10. Fleming BC, Spindler KP, Palmer M, et al. 2009. Collagen-platelet composites improve the biomechanical properties of healing ACL grafts in a porcine model. Am J Sports Med (in press).
11. Bell E. 2000. Tissue engineering in perspective. In: Lanza RP, Vacanti J, editors. Principles of tissue engineering. 2nd ed. San Diego: Academic Press. p xxxv-xli.
12. Hubbell JA. 2007. Matrix effects. San Diego: Academic Press. p 297-308.
13. Rieder E, Seebacher G, Kasimir MT, et al. 2005. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 111:2792-2797. (Pubitemid 40791551)
14. Chen RN, Ho HO, Tsai YT, et al. 2004. Process development of an acellular dermal matrix (ADM) for biomedical applications. Biomaterials 25:2679-2686.
15. Courtman DW, Pereira CA, Kashef V, et al. 1994. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mater Res 28:655-666. (Pubitemid 24148315)
16. Dumont CE, Hentz VR. 1997. Enhancement of axon growth by detergent-extracted nerve grafts. Transplantation 63:1210-1215.
17. Gilbert TW, Sellaro TL, Badylak SF. 2006. Decellularization of tissues and organs. Biomaterials 27:3675-3683.
18. Schmidt CE, Baier JM. 2000. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21:2215-2231.
19. Badylak SF. 2004. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol 12:367-377. (Pubitemid 38639730)
20. Grauss RW, Hazekamp MG, Oppenhuizen F, et al. 2005. Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods. Eur J Cardiothorac Surg 27:566-571. (Pubitemid 40409725)
21. Schenke-Layland K, Vasilevski O, Opitz F, et al. 2003. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 143:201-208. (Pubitemid 37297860)
22. Dahl S, Koh J, Prabhakar V, et al. 2003. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant 21:659-666. (Pubitemid 37204423)
23. Cartmell JS, Dunn MG. 2004. Development of cell-seeded patellar tendon allografts for anterior cruciate ligament reconstruction. Tissue Eng 10:1065-1075. (Pubitemid 39223786)
24. Woods T, Gratzer PF. 2005. Effectiveness of three extraction techniques in the development of a decellularized bone-anterior cruciate ligament-bone graft. Biomaterials 26:7339-7349. (Pubitemid 41133585)
25. Rieder E, Kasimir MT, Silberhumer G, et al. 2004. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg 127:399-405. (Pubitemid 38176643)
26. Chen R, Ho H, Tsai Y, et al. 2004. Process development of an acellular dermal matrix (ADM) for biomedical applications. Biomaterials 25:2679-2686. (Pubitemid 38147459)
27. Hudson T, Liu S, Schmidt C. 2004. Engineering an improved acellular nerve graft via optimized chemical processing. Tissue Eng 10:1346-1358. (Pubitemid 39557839)
28. Murray MM, Martin SD, Martin TL, et al. 2000. Histological changes in the human anterior cruciate ligament after rupture. J Bone Joint Surg [Am] 82:1387-1397. (Pubitemid 30796384)
29. Murray MM, Spector M. 2001. The migration of cells from the ruptured human anterior cruciate ligament into collagen-glycosaminoglycan regeneration templates in vitro. Biomaterials 22:2393-2402. (Pubitemid 32666230)
30. Hoemann CD. 2004. Molecular and biochemical assays of cartilage components. In: Ceuninck F, Pastoureau P, editors. Cartilage and osteoarthritis. Totowa, NJ: Humana Press; p 127-156.
31. Hoemann CD, Sun J, Chrzanowski V, et al. 2002. A multivalent assay to detect glycosaminoglycan, protein, collagen, RNA, and DNA content in milligram samples of cartilage or hydrogel-based repair cartilage. Anal Biochem 300:1-10. (Pubitemid 34066797)
32. Farndale RW, Buttle DJ, Barrett AJ. 1986. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883:173-177.
33. Smith J. 1997. Postcolumn amino acid analysis. In: Smith BJ, editor. Protein sequencing protocols. Totowa, NJ: Humana Press.
34. Arnoczky SP, Tarvin GB, Marshall JL. 1982. Anterior cruciate ligament replacement using patellar tendon. An evaluation of graft revascularization in the dog. J Bone Joint Surg [Am] 64:217-224.
35. Delay BS, McGrath BE, Mindell ER. 2002. Observations on a retrieved patellar tendon autograft used to reconstruct the anterior cruciate ligament. A case report. J Bone Joint Surg [Am] 84-A:1433-1438. (Pubitemid 35407590)
36. Gratzer PF, Harrison RD, Woods T. 2006. Matrix alteration and not residual sodium dodecyl sulfate cytotoxicity affects the cellular repopulation of a decellularized matrix. Tissue Eng 12:2975-2983. (Pubitemid 46141262)
37. Forslund C, Aspenberg P. 2003. Improved healing of transected rabbit Achilles tendon after a single injection of cartilage-derived morphogenetic protein-2. Am J Sports Med 31:555-559. (Pubitemid 36875387)
38. Rodeo SA, Potter HG, Kawamura S, et al. 2007. Biologic augmentation of rotator cuff tendon-healing with use of a mixture of osteoinductive growth factors. J Bone Joint Surg [Am] 89:2485-2497. (Pubitemid 350086340)
39. Spindler KP, Murray MM, Detwiler KB, et al. 2003. The biomechanical response to doses of TGF-beta 2 in the healing rabbit medial collateral ligament. J Orthop Res 21:245-249.
40. Freed LE, Vunjak-Novakovic G, Langer R. 1993. Cultivation of cell-polymer cartilage implants in bioreactors. J Cell Biochem 51:257-264. (Pubitemid 23103601)
41. Vunjak-Novakovic G, Obradovic B, Martin I, et al. 1998. Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol Prog 14:193-202. (Pubitemid 28202602)
42. Ingram J, Korrosis S, Fisher J, et al. 2005. Ultrasonic modification of acellular tendon to enhance recellularisation. Eur Cells Mater 10:14.
43. Tomford WW. 1995. Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg [Am] 77:1742-1754.
44. Stone KR, Abdel-Motal UM, Walgenbach AW, et al. 2007. Replacement of human anterior cruciate ligaments with pig ligaments: a model for anti-non-gal antibody response in long-term xenotransplantation. Transplantation 83:211-219.
45. Tohyama H, Yasuda K. 2000. Extrinsic cell infiltration and revascularization accelerate mechanical deterioration of the patellar tendon after fibroblast necrosis. J Biomech Eng 122:594-599. (Pubitemid 32047021)
46. Vavken P, Culen G, Dorotka R. 2008. Management of confounding in controlled orthopaedic trials: a cross-sectional study. Clin Orthop Relat Res 466:985-989.